Nuclear localized phosphorylated FADD induces cell proliferation and is associated with aggressive lung cancer

Mahaveer S Bhojani1, Guoan Chen, Brian D Ross

  • 1Department of Radiology, University of Michigan, Ann Arbor, Michigan 48109-0648, USA.

Insights

Phosphorylated FADD (p-FADD) in lung cancer cells is linked to increased NF-kB activity and poor survival. Elevated p-FADD levels may serve as a prognostic biomarker for lung cancer patients.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Fas-associated death domain (FADD) is known as a pro-apoptotic adaptor molecule.
  • Recent research highlights apoptosis-independent roles of FADD in cell cycle, proliferation, and NF-kB activation.
  • FADD overexpression in lung adenocarcinoma correlates with poor survival, independent of gene amplification or mutation.

Purpose of the Study:

  • To investigate the correlation between FADD localization, phosphorylation, NF-kB activity, and clinical outcome in lung cancer.
  • To evaluate the potential of phosphorylated FADD (p-FADD) as a prognostic biomarker.

Main Methods:

  • Analysis of FADD mRNA and protein levels in lung adenocarcinomas.
  • Assessment of FADD nuclear localization and phosphorylated FADD (p-FADD) expression.
  • Correlation analysis with NF-kB activity and patient survival data.

Main Results:

  • Increased FADD mRNA and protein levels are associated with poor survival in lung adenocarcinoma.
  • Nuclear localization of FADD and elevated p-FADD expression closely correlate with increased NF-kB activity.
  • Both nuclear FADD and elevated p-FADD correlate with poor clinical outcomes.

Conclusions:

  • Elevated nuclear FADD and p-FADD expression are linked to increased NF-kB activity and poor prognosis in lung cancer.
  • p-FADD levels show potential as a reliable prognostic biomarker for predicting lung cancer patient survival.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...